BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38868302)

  • 21. Bronchial aspirate obtained during bronchoscopy yields increased fungal load compared to bronchoalveolar lavage fluid in patients at risk of invasive aspergillosis and Pneumocystis pneumonia.
    Dellière S; Amar Y; Hamane S; Aissaoui N; Denis B; Bergeron A; Tazi A; Alanio A
    Med Mycol; 2023 Dec; 61(12):. PubMed ID: 37996394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy.
    Acet-Öztürk NA; Ömer-Topçu D; Vurat-Acar K; Aydın-Güçlü Ö; Pınar İE; Demirdöğen E; Görek-Dilektaşlı A; Kazak E; Özkocaman V; Ursavas A; Akalın H; Özkalemkaş F; Ener B; Ali R
    J Mycol Med; 2022 Nov; 32(4):101304. PubMed ID: 35738036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics and prognostic value of plasma cell-free DNA PCR in patients with invasive aspergillosis and mucormycosis.
    Moreno A; Mah J; Budvytiene I; Ho DY; Schwenk HT; Banaei N
    J Clin Microbiol; 2024 May; 62(5):e0039424. PubMed ID: 38602412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of cell-free DNA fungal polymerase chain reaction for invasive fungal disease evaluation in pediatric oncology and stem cell transplant patients.
    Kushner LE; Schwenk HT; Qin F; Boothroyd D; Aftandilian C
    Pediatr Blood Cancer; 2024 Jun; ():e31133. PubMed ID: 38943234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia.
    White PL; Price JS; Posso RB; Barnes RA
    Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
    Khot PD; Ko DL; Hackman RC; Fredricks DN
    BMC Infect Dis; 2008 May; 8():73. PubMed ID: 18510764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving the diagnosis of invasive aspergillosis by the detection of Aspergillus in broncho-alveolar lavage fluid: Comparison of non-culture-based assays.
    Guegan H; Robert-Gangneux F; Camus C; Belaz S; Marchand T; Baldeyrou M; Gangneux JP
    J Infect; 2018 Feb; 76(2):196-205. PubMed ID: 29248586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical performance of metagenomic next-generation sequencing for diagnosis of invasive fungal disease after hematopoietic cell transplant.
    Zhang X; Zhang L; Li Y; Wang N; Zhang Y
    Front Cell Infect Microbiol; 2024; 14():1210857. PubMed ID: 38590441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Applicability of the EORTC/MSG criteria for IFD in clinical practice.
    Rieger H; Lustig D; Barlow S; Ostermann H; Fiegl M; Peterson L; Rieger CT
    Ann Hematol; 2015 May; 94(5):847-55. PubMed ID: 25544029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Hoenigl M; Prattes J; Spiess B; Wagner J; Prueller F; Raggam RB; Posch V; Duettmann W; Hoenigl K; Wölfler A; Koidl C; Buzina W; Reinwald M; Thornton CR; Krause R; Buchheidt D
    J Clin Microbiol; 2014 Jun; 52(6):2039-45. PubMed ID: 24671798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples.
    Reinwald M; Spiess B; Heinz WJ; Vehreschild JJ; Lass-Flörl C; Kiehl M; Schultheis B; Krause SW; Wolf HH; Bertz H; Maschmeyer G; Hofmann WK; Buchheidt D
    Eur J Haematol; 2012 Aug; 89(2):120-7. PubMed ID: 22650156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative evaluation of galactomannan test with bronchoalveolar lavage and serum for the diagnosis of invasive aspergillosis in patients with hematological malignancies.
    Gupta A; Capoor MR; Shende T; Sharma B; Mohindra R; Suri JC; Gupta DK
    J Lab Physicians; 2017; 9(4):234-238. PubMed ID: 28966482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?
    Svensson T; Lundström KL; Höglund M; Cherif H
    Ups J Med Sci; 2017 Mar; 122(1):56-60. PubMed ID: 27739337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of invasive fungal disease in hospitalized patients with chronic obstructive pulmonary disease.
    Mohedano Del Pozo RB; Rubio Alonso M; Cuétara García MS
    Rev Iberoam Micol; 2018; 35(3):117-122. PubMed ID: 30078525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
    Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
    Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients.
    de Heer K; Gerritsen MG; Visser CE; Leeflang MM
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012399. PubMed ID: 31107543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current Algorithms in Fungal Diagnosis in the Immunocompromised Host.
    Lehrnbecher T; Becker K; Groll AH
    Methods Mol Biol; 2017; 1508():67-84. PubMed ID: 27837498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchoalveolar lavage fluid polymerase chain reaction for invasive pulmonary aspergillosis among high-risk patients: a diagnostic meta-analysis.
    Han Y; Wu X; Jiang G; Guo A; Jin Z; Ying Y; Lai J; Li W; Yan F
    BMC Pulm Med; 2023 Feb; 23(1):58. PubMed ID: 36750828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interpretation, pitfalls of biomarkers in diagnosis of invasive fungal diseases.
    Lass-Florl C; Alastruey-Izquierdo A; Gupta R; Chakroborti A
    Indian J Med Microbiol; 2022; 40(4):480-484. PubMed ID: 35970627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.